Last update 08 May 2025

HDACs x FLT3 x VEGFR2

Basic Info

Related Targets
HDACsFLT3VEGFR2

Related

1
Drugs associated with HDACs x FLT3 x VEGFR2
FLT3 inhibitors/HDAC inhibitors/VEGFR2 antagonists(Chinese Academy of Medical Sciences and Peking Union Medical College)
Target
FLT3 x HDACs x VEGFR2
Mechanism
FLT3 inhibitors [+2]
Active Org.
Beijing Union Medical College Hospital, Chinese Academy of Medical Sciences
Originator Org.
Beijing Union Medical College Hospital, Chinese Academy of Medical Sciences
Active Indication
Acute Myeloid Leukemia
Inactive Indication-
Drug Highest PhasePreclinical
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
100 Clinical Results associated with HDACs x FLT3 x VEGFR2
Login to view more data
100 Translational Medicine associated with HDACs x FLT3 x VEGFR2
Login to view more data
0 Patents (Medical) associated with HDACs x FLT3 x VEGFR2
Login to view more data
1
Literatures (Medical) associated with HDACs x FLT3 x VEGFR2
13 Mar 2025Journal of Medicinal Chemistry
Design, Synthesis, and Biological Evaluation of Novel Fms-Like Tyrosine Kinase 3/VEGFR2/Histone Deacetylase Inhibitors for the Treatment of Acute Myeloid Leukemia

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free